Mycosis fungoides and Sézary syndrome;Micosis fungoide y síndrome de Sézary

Actas Dermo-Sifiliograficas

Volumn 92, Issue 5, 2001, Pages 193-206

  Gómez Díez, Santiago ^a   Pérez Oliva, Narciso ^b  

^a NONE   (Spain)

^b NONE

Author keywords

Lymphoma; Mycosis fungoides; S zary syndrome

Indexed keywords

CLINICAL FEATURE; CORRELATION FUNCTION; ERYTHRODERMA; HELPER CELL; HUMAN; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MYCOSIS FUNGOIDES; PROGNOSIS; REVIEW; SEZARY SYNDROME; SKIN LYMPHOMA; SKIN MANIFESTATION;

EID: 0343773005     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(01)76470-8     Document Type: Article

References (140)

1. Willemze R, Kerl H, Sterry W, y cols. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the european organization for research and treatment of cancer. Blood 1997;90:354-71.
2. Lorincz AL. Cutaneous T-cell lymphoma (mycosis fungoides). Lancet 1996;347:871-6.
3. Diamandidou E, Cohen PR, Kurzrock R. Mycosis fungoides and Sézary syndrome. Blood 1996;88:2385-409.
4. Sézary A, Bouvrain Y. Erythrodermie avec présence des cellules monstrueuses dans le derme et le sang circulant. Bull Soc Fr Derm Syphiligr 1938;45:254-60.
5. Alibert JLM, ed. Tableau du plan fungoide. Description des maladies de la peau observées a l'Hopital St. Louis. Paris: Barroisl'Aine et fils, 1806;157. (Cit en: MacKie RM. Lymphomas and leukaemias. En: Champion RH, Burton JL, Ebling FJG, eds. Rook/Wilkinson/Ebling Textbook of Dermatology, 5.a ed. Oxford: Blackwell Scientific Publ; 1992:2107-34).
6. Alibert JLM, ed. Tableau du plan fungoide. Description des maladies de la peau observées a l'Hopital St. Louis. Paris: Barroisl'Aine et fils, 1806;157. (Cit en: MacKie RM. Lymphomas and leukaemias. En: Champion RH, Burton JL, Ebling FJG, eds. Rook/Wilkinson/Ebling Textbook of Dermatology, 5.a ed. Oxford: Blackwell Scientific Publ; 1992:2107-34).
7. Bazin PAE, ed. Lecons sur le traitement des maladies chroniques. Paris: Adrian De la Haye, 1870;425. (Cit en: MacKie RM. Lymphomas and leukaemias. En: Champion RH, Burton JL, Ebling FJG, eds. Rook/Wilkinson/Ebling Textbook of Dermatology, 5.a ed. Oxford: Blackwell Scientific Publ; 1992:2107-34).
8. Bazin PAE, ed. Lecons sur le traitement des maladies chroniques. Paris: Adrian De la Haye, 1870;425. (Cit en: MacKie RM. Lymphomas and leukaemias. En: Champion RH, Burton JL, Ebling FJG, eds. Rook/Wilkinson/Ebling Textbook of Dermatology, 5.a ed. Oxford: Blackwell Scientific Publ; 1992:2107-34).
9. Stansfeld AG, Diebold J, Kapanci Y, y cols. Updated kiel classification for lymphomas. Lancet 1988;1:292-3.
10. The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: aummary and sescription of a working formulation for clinical usage. Cancer 1982;49:2112-35.
11. Harris NL, Jaffe ES, Stein H, y cols. A revised european-american classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
12. Harris NL, Jaffe ES, Diebold J, y cols. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-airlie house, Virginia, november 1997. J Clin Oncol 1999;17:3835-49.
13. Weinstock MA, Horm JW. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA 1988;260:42-6.
14. Kock SE, Zackheim HS, Williams ML, Fletcher V, LeBoit PE. Mycosis fungoides beginning in childhood and adolescence. J Am Acad Dermatol 1987;17:563-70.
15. Vasseur E, Rybojad M, Vignon MD, Pauwells C, Morel P. Mycosis fungoïde de l'enfant. Trois cas. Ann Dermatol Venereol 1995;122:686-7.
16. Zackheim HS, McCalmont TH, Deanovic FW, Odom RB. Mycosis fungoides with onset before 20 years of age. Review of 24 patients and report of a case diagnosed at age 22 months. J Am Acad Dermatol 1997; 36:557-62.
17. Garzon MC. Cutaneous T cell lymphoma in children. Semin Cut Med Surg 1999;18:226-32.
18. Quaglino P, Zaccagna A, Verrone A, Dardano F, Bernengo MG. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course. Dermatology 1999;199:8-14.
19. Weinstock MA. Epidemiology of mycosis fungoides. Semin Dermatol 1994;13;154-9.
20. Dreno B, Celerier P, Fleischmann M, Bureau B, Litoux P. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sézary syndrome. Acta Derm Venereol (Stockh) 1994;74:355-7.
21. Zucker-Franklin D, Pancake B. The role of human T-cell lymphotropic viruses (HTLV-I and II) in cutaneus T-cell lymphomas. Semin Dermatol 1994;13:160-5.
22. Shohat M, Hodak E, Hannig H, Bodemer W, David M, Shohat B. Evidence for the cofactor role of human T-cell lymphotropic virus type 1 in mycosis fungoides and Sézary syndrome. Br J Dermatol 1999;141:44-9.
23. Boni R, Davis-Daneshfar A, Burg G, Fuchs D, Wood GS. No detection of HTLV-I proviral DNA in lesional skin biopsies from swiss and german patients with cutaneous T-cell lymphoma. Br J Dermatol 1996;134:282-4.
24. Li G, Vowels BR, Benoit BM, Rook AH, Lessin SR. Failure to detect human T-lymphotropic virus type-1 proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. J Invest Dermatol 1996;107:308-13.
25. Tan RSH, Butterworth CM, Mclaughlin H, Malka S, Samman PD. Mycosis fungoides a disease of antigen persistence. Br J Dermatol 1974;91:607-16.
26. Tuyp E, Burgoyne A, Aitchison T, MacKie R. A case-control study of possible causative factors in mycosis fungoides. Arch Dermatol 1987;123:196-200.
27. Whittemore AS, Holly EA, Lee I, y cols. Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. J Natl Cancer Inst 1989;81:1560-7.
28. Schneider BF, Christian M, Hess CE, Williams ME. Familial occurrence of cutaneous T cell lymphoma: a case report of monozygotic twin sisters. Leukemia 1995; 9:1979-81.
29. Gómez de la Fuente E, Barrientos Pérez N, Ortiz Romero PL, Álvarez Fernández JG, Vanaclocha Sebastián F, Iglesias Díez L. Etiopatogenia de los linfomas cutáneos de células T (micosis fungoide/síndrome de Sézary). Actas Dermosifiliogr 2000;91:477-83.
30. Johnson GA, Dewald GW, Strand WR, Winkelmann RK. Chromosome studies in 17 patients with the Sézary syndrome. Cancer 1985;55:2426-33.
31. Limon J, Nedoszytko B, Brozek I, y cols. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sézary syndrome. Cancer Genet Cytogenet 1995;83:75-81.
32. Thangavelu M, Finn WG, Yelavarthi KK, y cols. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood 1997;89:3371-7.
33. ink4a gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol 2000;156:1565-72.
34. Degos R. Mycosis fongoide. En: Degos R, ed. Dermatologíe. Paris: Flammarion; 1981:897-910a.
35. Martí RM, Estrach T. Linfomas cutáneos (I): linfomas T. Piel 1990;5:473-82.
36. Koh HK, Charif M, Weinstock MA. Epidemiology and clinical manifestations of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:943-60.
37. Sangüeza OM, Requena L. Variantes clinicopatológicas de la micosis fungoide. Actas Dermosifiliogr 1996;87:3-18.
38. Gómez Orbaneja J. Micosis fungoide. Síndrome o eritrodermia de Sézary. Enfermedad de Hodgkin. Aspectos clínicos e histológicos. Diagnóstico y diagnósticos diferenciales. Tratamiento. En: Gómez Orbaneja J, ed. Dermatología, 2.a ed. Madrid: Aguilar, S. A.; 1976:527-35.
39. Hoppe RT, Wood GS, Abel EA. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment. Curr Probl Cancer 1990;14:295-361.
40. Sánchez JL, Ackerman AB. The patch stage of mycosis fungoides. Criteria for histologic diagnosis. Am J Dermatopathol 1979;1:5-26.
41. MacKie RM. Lymphomas and leukaemias. En: Champion RH, Burton JL, Ebling FJG, eds. Rook/Wilkinson/Ebling Textbook of Dermatology, 5.a ed. Oxford: Blackwell Scientific Publ; 1992:2107-34.
42. Dauden Tello E, Valks R, Vargas-Díez E, Porras Luque JI, Fernández-Péffas P, Aragues Montahes M. Mucinosis folicular y micosis fungoide. Estudio de cinco casos y revisión de la literatura. Actas Dermosifiliogr 1996;87:450-8.
43. Bonta MD, Tannous ZS, Demierre MF, González E, Harris NL, Duncan LM. Rapidly progressing mycosis fungoides presenting as follicular mucinosis. J Am Acad Dermatol 2000;43:635-40.
44. Radeff B, Mérot Y, Saurat JH. Acquired epidermal cysts and mycosis fungoides. A possible piffall in clinical staging. Am J Dermatopathol 1988;10:424-9.
45. Oliwiecki S, Ashworth J. Mycosis fungoides with a widespread follicular eruption, comedones and cysts. Br J Dermatol 1992;127:54-6.
46. Lacour JP, Castanet J, Perrin C, Ortonne JP. Follicular mycosis fungoides. A clinical and histologic variant of cutaneous T-cell lymphoma: report of two cases. J Am Acad Dermatol 1993;29:330-4.
47. Miralles J, Pujol JM, Sole J, Casanovas JM, Moragas JM. Micosis fungoide foliculotropa. Actas Dermosifiliogr 1996; 87:467-70.
48. Pereyo NG, Requena L, Galloway J, Sangueza OP. Follicular mycosis fungoides: a clinicohistopathologic study. J Am Acad Dermatol 1997;36:563-8.
49. Hodak E, Feinmesser M, Segal T, y cols. Follicular cutaneous T-cell lymphoma: a clinicopathological study of nine cases. Br J Dermatol 1999;141:315-22.
50. Toribio J, Quiñones PA, Vigil TR. Woringer-Kolopp disease. Pagetoid reticulosis. Dermatologica 1978;156:283-91.
51. Mandojana RM, Helwig EB. Localized epidermotropic reticulosis (Woringer-Kolopp disease). A clinicopathologic study of 15 new cases. J Am Acad Dermatol 1983; 8:813-29.
52. Deneau DG, Wood GS, Beckstead J, Hoppe RT, Price N. Woringer-Kolopp disease (pagetoid reticulosis). Four cases with histopathologic, ultrastructural, and immunohistologic observations. Arch Dermatol 1984;120:1045-51.
53. Ketron LW, Goodman MH. Multiple lesions of the skin apparently of epithelial origin resembling clinically mycosis fungoides. Arch Derm Syph 1931;24:758-77.
54. Mielke V, Wolff HH, Winzer M, Sterry W. Localized and disseminated pagetoid reticulosis. Diagnostic immunophenotypical findings. Arch Dermatol 1989;125:402-6.
55. Yagi H, Hagiwara T, Shirahama S, Tokura Y, Takigawa M. Disseminated pagetoid reticulosis: need for long-term follow-up. J Am Acad Dermatol 1994;30:345-9.
56. Oliver GF, Winkelmann RK. Unilesional mycosis fungoides: a distinct entity. J Am Acad Dermatol 1989;20:63-70.
57. Soria Martínez C, Allegue Rodríguez F, Santamaría Carrillo M, Rocamora Ripoll A, Moreno Izquierdo R, Ledo Pozueta A. Micosis fungoide unilesional. Actas Dermosifiliogr 1990;81:211-3.
58. Verret JL, Rousselet MC, Peria P. Mycosis fongoïde unilésionnel en plaque. 3 observations. Ann Dermatol Venereol 1997;124:527-30.
59. Heald PW, Glusac EJ. Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant. J Am Acad Dermatol 2000;42:283-5.
60. Burns MK, Chan LS, Cooper KD. Woringer-Kolopp disease (localized pagetoid reticulosis) or unilesional mycosis fungoides? An analysis of eight cases with benign disease. Arch Dermatol 1995;131:325-9.
61. Barnhil RL, Braverman IM. Progression of pigmented purpura-like eruptions to mycosis fungoides: report of three cases. J Am Acad Dermatol 1988;19:25-31.
62. Toro JR, Sander CA, LeBoit PE. Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? A study by light microscopy and molecular methods. Am J Dermatopathol 1997;19:108-18.
63. Lipsker D, Cribier B, Heid E, Grosshans E. Lymphomes cutanés révélés par des capillarites, purpuriques et pigmentaires. Ann Dermato Venereol 1999;126:321-6.
64. Samman PD. Mycosis fungoides and other cutaneous reticuloses. Clin Exp Dermatol 1976;1:197-214.
65. Zackheim HS, Epstein EH, Grekin DA, McNutt NS. Mycosis fungoides presenting as areas of hypopigmentation. J Am Acad Dermatol 1982;6:340-5.
66. Akaraphanth R, Douglass MC, Lim HW. Hypopigmented mycosis fungoides: treatment and a 61/2-year follow-up of 9 patients. J Am Acad Dermatol 2000;42:33-9.
67. Córdoba S, Fernández-Herrera J, Sánchez-Pérez J, Fraga J, García-Díez A. Vesiculobullous mycosis fungoides. Br J Dermatol 1999;141:164-5.
68. Resnik KS, Kantor GR, Lessin SR, y cols. Mycosis fungoides palmaris et plantaris. Arch Dermatol 1995;131:1052-6.
69. LeBoit PE. Variants of mycosis fungoides and related cutaneous T-cell lymphomas. Semin Diagn Pathol 1991;8:73-81.
70. Pujol RM, Gallardo F, Llistosella E, y cols. Invisible mycosis fungoides: a diagnostic challenge. J Am Acad Dermatol 2000;42:324-8.
71. Mouly F, Baccard M, Cayuela JM, y cols. Cutaneous T-cell lymphoma associated with granulomatosis slack skin. Dermatology 1996;192:288-90.
72. Noto G, Pravata G, Miceli S, Arico M. Granulomatous slack skin: report of a case associated with Hodgkin's disease and a review of the literature. Br J Dermatol 1994;131:275-9.
73. Winkelmann RK, Buechner SA, Diaz-Perez JL. Pre-Sézary syndrome. J Am Acad Dermatol 1984;10:992-9.
74. Wieselthier JS, Koh HK. Sézary syndrome: diagnosis, prognosis, and critical review of treatment options. J Am Acad Dermatol 1990;22:381-401.
75. LeBoit PE, McCalmont TH. Cutaneous lymphomas and leukemias. En: Elder D, Elenitsas R, Jaworsky C, Johnson B, eds. Lever's histopathology of the skin, 8.a ed. Philadelphia: Lippincott-Raven; 1997:805-46.
76. Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol 1994;18:645-67.
77. Nickoloff BJ. Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides. Am J Dermatopathol 1988;10:469-77.
78. Salhany KE, Cousar JB, Greer JP, Casey TT, Fields JP, Collins RD. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol 1988;132:265-77.
79. Buechner SA, Winkelmann RK, Sézary syndrome. A clinicopathologic study of 39 cases. Arch Dermatol 1983; 119:979-86.
80. Sentis HJ, Willemze R, Scheffer E. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. J Am Acad Dermatol 1986;15:1217-26.
81. Kohler S, Kim YH, Smoller BR. Histologic criteria for the diagnosis of erythrodermic mycosis fungoides and Sézary syndrome: a critical reappraisal. J Cutan Pathol 1997;24:292-7.
82. Martí Laborda RM, Estrach Panella T. Linfomas cutáneos. Med Cután Iber Lat Am 1998;XXVI:113-36.
83. Izban KF, Hsi ED, Alkan S. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections. Mod Pathol 1998;11:978-82.
84. Knowles DM. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. Am J Pathol 1989;134:761-85.
85. Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol 1990;22:569-77.
86. Van der Putte SC, Toonstra J, Van Wichen DF, Van Unnik JA, Van Vloten WA. Aberrant immunophenotypes in mycosis fungoides. Arch Dermatol 1988;124:373-80.
87. Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM. Primary cutaneous T-cell lymphomas: review and current concepts. J Clin Oncol 2000;18:2908-25.
88. Wood GS, Tung RM, Haeffner AC, y cols. Detection of clonal T-cell receptor gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 1994;103:34-41.
89. Bachelez H, Bioul L, Flageul B, y cols. Detection of clonal T-cell receptor gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome. Arch Dermatol 1995;131:1027-31.
90. Bergman R, Faclieru D, Sahar D, y cols. Immunophenotyping and T-cell receptor gene rearrangement analysis as an adjunct to the histopathologic diagnosis of mycosis fungoides. J Am Acad Dermatol 1998;39:554-9.
91. Guitart J, Kaul K. A new polymerase chain reaction-based method for the detection of T-cell clonality in patients with possible cutaneous T-cell lymphoma. Arch Dermatol 1999;135:158-62.
92. Springer EA, Kuzel TM, Rosen ST, Roenigk HH. Intenational Symposium on Cutaneous T Cell Lymphoma. J Am Acad Dermatol 1991;24:136-8.
93. Bunn PA, Lamberg Sl. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979;63:725-8.
94. Sausville EA, Eddy JL, Makuch RW, y cols. Histopathologic staging at initial diagnosis of mycosis fungoides and Sézary syndrome. Definition of three distinctive prognostic groups. Ann Intern Med 1988;109:372-82.
95. Epstein EH, Levin DL, Croft JD, Lukner MA. Mycosis fungoides. Survival, prognostic features, response to therapy, and autopssy findings. Medicine 1972;15:61-72.
96. Fuks ZY, Bagshaw MA, Farber EM. Prognostic signs and the management of the mycosis fungoides. Cancer 1973; 32:1385-95.
97. Green SB, Byar DP, Lamberg SI. Prognostic variables in mycosis fungoides. Cancer 1981;47:2671-7.
98. Hamminga L, Hermans J, Noordijk EM, Meijer CJLM, Scheffer E, Van Vloten WA. Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients. Br J Dermatol 1982;107:145-56.
99. Slevin NJ, Blair V, Todd IDH. Mycosis fungoides-response to therapy and survival patterns in 85 cases. Br J Dermatol 1987;116:47-53.
100. Marti RM, Estrach T, Reverter JC, Mascaro JM. Prognostic clinicopathologic factors in cutaneous T-cell lymphoma. Arch Dermatol 1991;127:1511-6.
101. Toro JR, Stoll HL, Stomper PC, Oseroff AR. Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome. J Am Acad Dermatol 1997;37:58-67.
102. Zackheim HS, Amin S, Kashani-Sabet M, McMillan A Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol 1999;40:418-25.
103. Kim YH, Chow S, Varghese A, Hoppe RT. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 1999;135:26-32.
104. Diamandidou E, Colome M, Fayad L, Duvic M, Kurzrock R. Prognostic factor analysis in mycosis fungoides/Sézary syndrome. J Am Acad Dermatol 1999;40:914-24.
105. Van Doom R, Van Haselen CW, Van Voorst PC, y cols. Mycosis fungoides. Disease evolution and prognosis of 309 dutch patients. Arch Dermatol 2000; 136:504-10.
106. Wasik MA, Vonderheid EC, Bigler RD, y cols. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Arch Dermatol 1996;132:42-7.
107. Hoppe RT, Medeiros LJ, Warnke RA, Wood GS. CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 1995;32:448-53.
108. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage IA (limited patch and plaque) mycosis funfoides. A long-term outcome analysis. Arch Dermatol 1996;132:1309-13.
109. Kim YH, Bishop K, Varghese A, Hoppe RT. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. Arch Dermatol 1995;131:1003-8.
110. Dmitrovsky E, Matthews MJ, Bunn PA, y cols. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol 1987;5:208-15.
111. Cerroni L, Rieger E, Hodl S, Kerl H. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol 1992;16:543-52.
112. Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood 1998;92:1150-9.
113. Vergier B, de Muret A, Beylot-Barry M, y cols. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. Blood 2000;95:2212-18.
114. Zackheim HS, Kashani-Sabet M, Amin S. Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Arch Dermatol 1998;134:949-54.
115. Zackheim HS. Treatment of cutaneous T-cell lymphoma. Semin Dermatol 1994; 13:207-15.
116. Zackheim HS. Cutaneous T cell lymphoma: update of treatment. Dermatology 1999;199:102-5.
117. Ramsay DL, Meller JA, Zackheim HS. Topical treatment of early cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:1031-56.
118. Zackheim HS. Topical carmustine (BCNU) for patch/plaque mycosis fungoides. Semin Dermatol 1994;13:202-6.
119. Ramsay DL, Lish KM, Yalowitz CB, Soter NA. Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma. Arch Dermatol 1992;128:931-3.
120. Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 1999;135:1377-80.
121. Herrmann JJ, Roenigk HH, Honigsmann H. Ultraviolet radiation for treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:1077-88.
122. Richard-Lallemand MA, Carsuzaa F. Mycosis fongoide. Ann Dermatol Venereol 1997;124:69-90.
123. Molin L, Thomsen K, Volden G, y cols. Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol (Stockh) 1987;67:232-6.
124. Thomsen K, Hammar H, Molin L, Volden G. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol (Stockh) 1989;69:536-8.
125. De Misa Gabrera RF, Azaña Defez JM, Harto Castaño A, Moreno Izquierdo R. La fotoquimioterapia extracorpórea en el tratamiento del linfoma cutáneo de células T. Actas Dermosifiliogr 1995;86:563-72.
126. Olsen EA, Rosen ST, Vollmer RT, y cols. Interferon alfa2a in the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol 1989;20:395-407.
127. Vonderheid EC, Thompson R, Smiles KA, Lattanand A. Recombinant Interferón alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy. Arch Dermatol 1987;123:757-63.
128. Kuzel TM, Gilyon K, Springer E, y cols. Interferón alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 1990;82:203-7.
129. Mostow EN, Neckel SL, Oberhelman L, Anderson TF, Cooper KD. Complete remissions in psoralen and UV-A (PUVA) refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined Interferon alfa and PUVA. Arch Dermatol 1993;129:747-52.
130. Hoppe RT. The manegement of mycosis fungoides at Stanford-standard and innovative treatment programmes. Leukemia 1991;5(suppl 1):46-8.
131. Hamminga B, Noordijk EM, Van Vloten W. Treatment of mycosis fungoides. Total-skin electron-beam irradiation vs topical mechlorethamine therapy. Arch Dermatol 1982;118:150-3.
132. Quirós PA, Jones GW, Kacinski BM, y cols. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiation Oncology Biol Phys 1997;38:1027-35.
133. Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. Arch Dermatol 1995;131:432-35.
134. Rosen ST, Foss FM. Chemotherapy for mycosis fungoides and the Sézary syndrome. Hematol Oncol Clin North Am 1995;9:1109-16.
135. Holloway KB, Flowers FP, Ramos-Caro FA. Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 1992;27:367-78.
136. Duvic M, Lemak NA, Redman JR, y cols. Combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996;34:1022-9.
137. De Misa Cabrera RF, Azaña Defez JM, Harto Castaño A. Alternativas terapéuticas en la micosis fungoide y el síndrome de Sézary. Piel 1996;11:124-34.
138. Winkelmann RK, Díaz-Pérez JL, Buechner SA. The treatment of Sézary syndrome. J Am Acad Dermatol 1084; 10:1000-4.
139. Zackheim HS, Epstein EH. Low-dose methotrexate for the Sézary syndrome. J Am Acad Dermatol 1989;21:757-62.
140. Fraser-Andrews E, Seed P, Whittaker S, Russell-Jones R. Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone. Arch Dermatol 1998;134:1001-5.